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Chronic obstructive pulmonary disease (COPD) is the most frequent chronic disease in 
developed countries and is predicted to be the third cause of death in 2020. Lung cancer is the 
leading cause of cancer death both in men and women. A vast majority of patients diagnosed 
with lung cancer have COPD, a history of tobacco use, or both. Shared inflammatory pathways 
may govern the pathogenesis of COPD and lung cancer. Several studies imply a relationship 
between COPD and lung cancer, but there is very limited information in the literature about 
emphysema and lung cancer risk. The Carinal Registry is a prospectively collected case series of 
patients diagnosed with lung cancer at the University of Pittsburgh. Among other data, it 
contains information on COPD that was acquired from the medical record (yes/no entry). Our 
goal was to evaluate the data quality and decide if the COPD variable could be used to score for 
emphysema. For this purpose, we adapted a subjective, semi-quantitative, visual emphysema 
scoring method (VESM) to score emphysema severity on C T scans and compared this 
emphysema severity score with the presence or absence of emphysema as defined in the Carinal 
Registry. We defined the best CT to score emphysema to be obtained preferably within one year 
preoperatively, with lung edge-enhancing reconstruction algorithm. Training in VESM showed 
high reproducibility scores and high sensitivity of the trainee to detect emphysema when 
compared to the standard expert score. Our results showed that there was poor correlation 
between the COPD status as recorded from the COPD variable from medical records and the 
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VESM. The VESM was a more accurate measure of COPD status among lung cancer patients 
enrolled in the Carinal Registry. Moreover, we compared the distribution of COPD among lung 
cancer patients and the community adapted from Wilson et al. manuscript who carried out a 
community based screening study for lung cancer among smokers. Our results showed that the 
distribution of COPD was similar among both populations, suggesting the possibility of an 
underlying common pathway of lung cancer and emphysema.  
 
Public Health Significance: 
The public health significance of this study is clearly explained by the high frequency of both 
emphysema and lung cancer and the dismal prognosis of lung cancer. We have studied a sample 
of a large case series of lung cancer patients and scored their emphysema severity with a semi-
quantitative method based on CT scan reading. We have also compared this method with simply 
retrieving emphysema data from the medical record and assessed the validity of these methods. 
All the above mentioned are very important reasons that can affect the public health as well as 
research purposes. 
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1.0  RATIONALE AND BACKGROUND 
Chronic obstructive pulmonary disease (COPD) is the most frequent chronic disease in 
developed countries and is predicted to be the third cause of death in 2020 (1). According to the 
Third National Health and Nutrition Examination Survey (NHANES III), COPD affects 
approximately 10% of the United States adult population. COPD is a multicomponent disease 
that can be evaluated and characterized by spirometry to assess functional capacity and imaging 
to assess distribution and extent of the disease (2). 
Lung cancer has a worldwide incidence of 1.2 m illion cases. In the United States the 
estimated annual death rate due to this disease for 2010 ( 157,300) approximates its annual 
incidence rate (222,520), making it the leading cause of cancer deaths in both men and women in 
the United States (3). 
A vast majority of patients diagnosed with lung cancer have COPD, a history of tobacco 
use, or both (40-70%). However, only a minority of long term smokers (10-15%) develops 
COPD (4). The pathophysiology of COPD and emphysema is characterized by luminal airway 
narrowing and destruction of lung parenchyma driven by inflammation. Thus, shared 
inflammatory pathways may govern the pathogenesis of COPD and lung cancer (5,6). The role 
of chronic airway inflammation induced by cigarette smoke is an active area of research. It 
remains unclear whether COPD is in the causal pathway of lung cancer or whether both COPD 
and lung cancer are related to an underlying exposure, or a combination of both. However, it has 
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also been shown that even in non-smokers, the presence of COPD alone increases the risk of 
developing lung cancer (7,8). 
Several studies imply a relationship between chronic obstructive pulmonary disease and 
lung cancer, but there is very limited information in the literature about specifically emphysema 
and lung cancer risk. A nested case control study by Maldonado et al. (9) from the Mayo Clinic, 
in which patients were pulled from a screening study and scored for emphysema with software in 
an objective manner, revealed no association between radiographic emphysema and the risk of 
lung cancer. However, Wilson et al (10) studied subjects in the frame of the Pittsburgh Lung 
Screening Study (PLuSS), which is a subproject of the University of Pittsburgh Lung Cancer 
Specialized Program of Research Excellence (SPORE). The aforementioned is a community-
based study of lung cancer screening that used low dose multi-detector helical CT (LDCT) and 
pulmonary function tests (PFT) as part of its assessment of emphysema. The authors reported an 
increased frequency of lung cancer in subjects with emphysema, with the highest frequency 
observed in subjects with both emphysema and moderate–severe airflow obstruction. Their main 
finding was that for any level of tobacco exposure, patients with chronic airflow obstruction 
were at greater risk for lung cancer than smokers without airflow obstruction. This relationship 
proved to be severity dependent; where individuals with the worst lung function showed the 
highest risk. De Torres et al. studied a prospective cohort of individuals enrolled in a lung cancer 
screening study that also used LDCT and found that the incidence density of lung cancer among 
individuals with emphysema on LDCT was 25.0 per 1,000 person-years and only 7.5 per 1,000 
person-years among individuals without emphysema (11). Littman et al. as well reported a 
positive association between radiographic emphysema and the risk of lung cancer (12). 
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The Carinal Registry is a prospectively collected case series of patients diagnosed with 
lung cancer that started in 1990 at the University of Pittsburgh. These patients underwent surgery 
and/or had blood/tissue collected. The Carinal Registry possesses deficient emphysema 
information. The current problems that researchers face are based upon one fact: the data were 
not collected for research purposes, but in the clinical environment. These data were not 
collected using a standard protocol. For example, COPD data in the Carinal Registry comes from 
medical records and not from direct CT scan study reading. In addition, it is a retrospective 
analysis. Researchers also face data quality problems that can be partially due to variability in 
equipment, such as advances in electronic medical records, CT image acquisition and CT image 
reconstruction protocol changes throughout the years, CT technology improvement between 
2002 and 2009, technical problems such as motion artifact, and other unexpected issues such as 
interim health problems obscuring the image (pleural effusion, pneumonia, post-operative 
changes). 
The objectives of this study are three fold as described by the Specific Aims. 
1.1 SPECIFIC AIM 1 
Data analysis: To perform a s ystematic evaluation of research procedures designed to retrieve 
structural emphysema data for participants in a lung cancer database. 
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1.1.1 Systematic Database Evaluation 
Using 2002-2009 Carinal Registry patients as our study base, we described the proportion of 
different gender, ethnic groups, age group, and histological types of lung cancer. The 
completeness of data entered from the medical history as emphysema/COPD, asthma, bronchitis 
and PFT results was evaluated. The frequency of smokers, both current and former and the 
distribution of pack years among them were analyzed. We looked at the family history and 
specifically described how many patients have a positive family history of lung cancer, other 
tobacco related cancers, or non-tobacco related cancer. All this information was evaluated in the 
Pilot Study (random sample from Carinal Registry, resource driven) as well. 
1.1.2 Systematic Analysis of CT information 
We analyzed the availability of CT studies. CT scans were divided in pre-diagnosis, post-
diagnosis, pre-operative and post-operative. Specific reconstruction parameters (edge-enhancing 
lung algorithm) mA dose and slice thickness used in these studies were also evaluated. 
1.2 SPECIFIC AIM 2 
Emphysema and Lung Cancer: To describe the distribution of emphysema among lung cancer 
patients. 
We described the distribution and frequency of COPD and emphysema among lung 
cancer patients. All patients enrolled in the Carinal Registry have lung cancer and most 
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underwent CT scan study. CT scans were retrieved and scored for emphysema based on the 
National emphysema Treatment Trial (NETT) protocol (see Methods) (13). These results were 
compared to the emphysema scores reported by Wilson et al. (10). 
1.3 SPECIFIC AIM 3 
Validation of Data in a Lung Cancer Database 
1.3.1 To validate data in the Carinal Registry database 
Data validation was carried out by comparison of the frequencies and distribution of the COPD 
variable from the Pilot Study (information obtained from the medical records) with the Visual 
Emphysema Score Method (VESM) after reading the CT scans for emphysema according to the 
NETT standards. 
1.3.2 To assess the reproducibility of the visual emphysema scoring method 
Intra-rater variability of VESM was assessed as a m easure of reliability. CT scans were 
independently read and results were compared using a weighted kappa statistic. Inter-rater 
variability of VESM was assessed as well as a measure of reliability, by comparing CT scan 
scoring from the trainee vs. the expert scoring of the three training modules and the Pilot Study 
CT scans. 
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2.0  METHODS 
2.1 DATABASE AND PATIENT POPULATION 
The database used for this study is the Carinal Registry version 12, downloaded July 2nd 2010. It 
is a prospectively collected database of lung cancer patients who had tissue and/or blood sample 
collected. It contains demographic information, specimen information (sample received date, 
sample type, pathology information, lung cancer staging), social history, family history, medical 
history, and Pulmonary Function Test (PFT) results. The sub-sample used in this study is a 
stratified random sample of 64 patients from an original sample of 548 patients diagnosed with 
lung cancer that had blood and tissue sample collected between 2002 and 2009. S pecific 
inclusion criteria as shown in Figure 1 are: (1) unique SSN Medical Record Number; (2) any 
lung cancer; (3) first lung cancer sample received between years 2002-2009; (4) lung cancer 
histology non-missing and non-carcinoid; (5) sample received within 12 months of diagnosis; (6) 
patient not enrolled in PLuSS; (7) patient had blood collected; (6) age at diagnosis >50; (7) 
positive smoking history; (8) 10+ pack-years. 
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Figure 1.  Sample Selection Strategy. 
Algorithm followed to select Carinal Registry Sample Set of 548 patients. 
 
2.2 SAMPLE SELECTION STRATEGY 
A Pilot Sample was selected according to two stratifying variables. These were year of 
enrollment in database (8 years, from 2002 to 2009) and whether or not the patient had a 
Pulmonary Function Test (PFT) performed with available result present in the database; giving a 
total of 16 strata. This pilot sample was randomly selected using an equal allocation technique 
with a selection of a fixed number of sampling units (n=4) from each of the stratum (14) (Figure 
2). Our goal was to obtain a balanced sample of the entire database since we were interested in 
having good representation from all patients. The selection of a smaller Pilot Sample was 
resource driven. 
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Figure 2. Pilot Sample Selection Technique. 
Disproportionate Sampling Fraction with equal allocation (n=4). 
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2.3 CT IMAGING INTERPRETATION PROTOCOL AND TRAINING IN THE 
VISUAL EMPHYSEMA SCORING METHOD 
All chest CT scans were obtained following standard protocols at the University of Pittsburgh 
Medical Center (UPMC). However, the CT scans used in this study were not obtained under one 
single CT image acquisition protocol. 
CT images were viewed on a  Picture Archiving and Communication System (PACS) 
monitor display system (iSite Radiology Launcher, Stentor iSite Enterprise and Single View, 
Philips, 15) using standard and lung window settings. 
Scoring procedures followed a semi-quantitative five level scale based on N ational 
Emphysema Treatment Trial (NETT) standards, representing no, t race, mild, moderate and 
severe emphysema (levels 0-4). CT scans with emphysema corresponding to the NETT standards 
1.5-3.0 and >3.0 were placed into moderate and severe categories, respectively. Mild 
emphysema was defined by the clear presence of emphysema (usually seen only in upper lobes), 
which was less severe than the NETT 1.5 standard. Trace emphysema was defined by a definite 
finding of minimal emphysema, typically characterized by scattered centrilobular lucencies in 
the upper lobes (13,16). 
A training module of 96 CT scans was developed by an expert thoracic radiologist for the 
visual emphysema scoring method. This training module was divided into 5 work-lists with CT 
scans pertaining at each of the five above mentioned emphysema severity categories. After 
reviewing the cases, these were joined in one single list in alphabetical order where there was no 
information available on the expert’s score. The CT scans were scored twice, in two independent 
occasions and compared to the expert score. A third and final training session was created by 
randomly pulling 24 CT scans from PLuSS. These CT scans were new to the reader; the reader 
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had never seen neither the set nor the expert score before. Agreement was calculated with 
weighted kappa. 
2.4 RETRIEVING CT SCAN DATA FOR THE PILOT STUDY 
An automated search strategy using UPMC MARS Electronic Search Procedure (UPMC MARS 
ESP) was developed to find all CT scan studies of the 548 pa tients enrolled in the Carinal 
Registry. The search strategy was validated manually and it showed to be accurate. A missing 
CT field was defined as no CT report in MARS and no CT study images in the entire PACS 
system. A separate spreadsheet was built filtered to any thoracic CT with or without contrast 
(exam type including angiography, abdominal, total body CT, PET scan), sequence (before and 
after date of lung cancer diagnosis), patient identifiers, exam date, and hospital provider data for 
the 64 patients in the Pilot Study. ISite Radiology Launcher was used to build work lists. This 
application is hospital-specific requiring eight different work-lists to be built (one work list for 
each of 8 UPMC facilities). The ESP search procedure identified one or more thoracic CT scans 
for 60 patients in the Pilot Study- 4 patients did not have a CT scan in MARS, see below).  
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2.5 RESEARCH DESIGN 
2.5.1 Visual Emphysema Scoring Method of CT studies (VESM) 
The training module on emphysema scoring was reviewed and scored for emphysema in two 
independent occasions by the trainee. In addition, a final set of 24 i ndependent and randomly 
selected CT scans was scored. Agreement was calculated by weighted kappa statistic. After 
completion of the training, the Pilot Study CT scans were scored for emphysema and compared 
to the expert reading as well. The expert score was used in further analysis due to poor 
agreement between the expert and the trainee scores. 
3.5.1. Reliability 
Intra-observer agreement was calculated between the first and second reading of the same 
training module by the same trainee. Inter-observer agreement was calculated between the 
expert’s and trainee’s readings of the three training sessions and the Pilot Study CT scan scoring 
(Appendix B). 
2.5.2 Validity 
The severity of emphysema as scored using the VESM both by the expert panel and trainee were 
compared. Sensitivity of the trainee to detect any emphysema was calculated for the three 
training sessions. The VESM score variable was condensed from 5 categories to only two, to 
detect either any emphysema or more than trace. 
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2.6 DATA ANALYSIS 
2.6.1 Systematic Analysis of Database 
To better characterize the study subjects, the demographics (age, race, and gender) among the 
individuals enrolled in the Carinal Registry and Pilot Study were analyzed. Additional variables 
in Carinal Registry and Pilot Study that we analyzed include: histological diagnosis, family 
history of cancer, relatives with lung cancer, relatives with other smoking-related cancer, 
relatives with non-tobacco-related cancer, smoking status, pack years smoked, medical history 
data on pulmonary disease (COPD, bronchitis, asthma), and availability of PFT data. 
2.6.2 Software 
Microsoft Access was used to develop the data collection forms and for storage and management 
of the data. Microsoft Visual Basic was used to number the samples.  Stentor iSite Enterprise, 
iSite Radiology Launcher and Single View were used to view and score CT scans for 
emphysema (15).  The electronic medical records resource used was MARS (Founded by John 
Vries, M.D. in 1989 at the University of Pittsburgh). All statistical analysis was performed using 
SAS software (SAS version 9.2; SAS Institute; Cary, NC). 
13 
2.6.3 Statistical Analysis 
Comparisons between readers were made using weighted kappa score since observations were in 
the ordinal scale. Agreement was scored and interpreted as excellent if kappa was between 0.75 
and 1.0, fair to good if kappa was between 0.4 and 0.75 and poor agreement if kappa was < 0.4 
(17). Statistical tests (chi-square, Wilcoxon sum rank test) used a two-sided significance level of 
p<0.05. Separate analysis modeled the VESM variable as a 5-category variable (0: none, 1: trace, 
2: mild, 3: moderate, 4: severe) to a 2 category variable (no/any emphysema) in order to compare 
with COPD variable (yes/no). 
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3.0  RESULTS 
3.1 SPECIFIC AIM 1 
3.1.1 Systematic Database Evaluation 
Carinal Registry: Subject Characteristics 
In the Carinal Registry, 50% of the participants are of female gender with a m ean age of 68 
(+8.25) (17%, 37.8%, 36.3%, and 8.9% of people aged 50-59, 60-69, 70-79, >80 respectively) 
and white race predominance (83% white, 7.5% black, 0.7% hispanic, 8.8% other). The different 
histological types of the tumors included Adenocarcinoma 42.7%, Squamous Cell Carcinoma 
34.5%, Non-Small Cell Lung Carcinoma (NSCLC) 9.9%, Adenosquamous carcinoma 4.6%, 
Small Cell Lung Carcinoma (SCLC) 2.9%, Large Cell Carcinoma 2.6%, Neuroendocrine 1.6%, 
and Bronchiolo-Alveolar Carcinoma (BAlCa) 1.3%. All participants were ever smokers, 46.2% 
were current smokers and 51.8% former. Half of the study population smoked for 30 to 60 years 
(median 40, interquartile range of 20). The distribution according cigarette dose exposure (pack-
years) was 16.8% (<30), 24.5% (30-44), 20.3% (45-59), 16.2% (60-74), 22.3% (>75) with a 
mean of 53.9 (+27.83) and a median of 50 pack-years (interquartile range 38).  
Almost 50% of the patients had a positive family history of cancer. Among the 
participants, 13.7% had a first degree relative with a lung tumor and 2.7% had a second degree 
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relative with a lung tumor. Ten percent had a history of one family member with a tobacco 
related cancer; while for non-tobacco related cancer 23.54% had one family member and 8.6% 
had two. 
The great majority of the patients reported a history of COPD/emphysema (66.9%, with 
41.6% missing data for this variable), bronchitis (13.99%, 74% missing data) or asthma (16.5%, 
70% missing data). The information in the COPD variable, as for most of the variables in this 
database is obtained from the medical history. It is a variable coded as yes/no or missing. 
Only 54% of patients had PFT information available in the Carinal Registry. Table 1 
shows the demographics and smoking distribution according to the COPD status, excluding 
subjects with missing COPD data. 
Table 1. Demographics and Smoking in the Carinal Registry population and Pilot Study sub-group by COPD status. 
 Carinal Registry Pilot Sample 
Variables 
COPD Status COPD Status 
No Yes Missing No Yes Missing 
N (%) N (%) N (%) N (%) N (%) N (%) 
Sex 
55 (20.1) 
 
103 (37.6) 
 
116 (42.34) 
 
10 (31.3) 
 
10 (31.3) 
 
12 (37.5) Female 
Male 51 (18.6) 111 (40.5) 112 (40.9) 5 (15.6) 10 (31.3) 17 (53.13) 
Age categories 
24 (25.8) 
 
25 (26.9) 
 
44 (47.3) 
 
4 (25) 
 
2 (12.5) 
 
10 (62.5) 50-59 years 
60-69 years 36 (17.4) 75 (36.2) 96 (46.4) 5 (27.8) 8 (44.4) 5 (27.8) 
70-79 years 33 (16.6) 96 (48.2) 70 (35.2) 4 (16.7) 7 (29.2) 13 (54.2) 
>=80 years 13 (26.5) 18 (36.7) 18 (36.7) 2 (33.3) 3 (50)  1 (16.7) 
Race 
80 (17.6) 
 
189 (41.5) 
 
186 (40.9) 
 
12 (23.5) 
 
16 (31.4) 
 
23 (45.1) White 
Black 11 (26.8) 12 (29.3) 18 (43.9) 1 (14.3) 2 (28.6)  4 (57.1) 
Other 15 (29.2) 13 (27.1) 24 (43.6) 2 (33.3) 2 (33.3)  2 (33.3) 
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 Carinal Registry Pilot Sample 
Variables 
COPD Status COPD Status 
No Yes Missing No Yes Missing 
N (%) N (%) N (%) N (%) N (%) N (%) 
Smoker Status 
43 (17) 
 
100 (39.5) 
 
110 (43.5) 
 
4 (14.3) 
 
10 (35.7) 
 
14 (50) Current Smoker 
Ex-smoker 62 (21.8) 112 (39.4) 110 (38.7) 10 (29.4) 10 (29.4)  14 (41.2) 
Pack Years categories 
24 (26.1) 
 
27 (29.4) 
 
41 (44.6) 
 
3 (30) 
 
2 (20) 
 
5 (50) <30 Pack-Years 
30-44 Pack-Years 31 (23.1) 39 (29.1) 64 (47.8) 2 (12.5) 6 (37.5)  8 (50) 
45-59 Pack-Years 17 (15.3) 46 (41.4) 48 (43.2) 2 (15.4) 5 (38.5) 6 (46.2) 
60-74 Pack-Years 14 (15.7) 41 (46.1) 34 (38.2) 2 (16.7) 4 (33.3)  6 (50) 
>75 Pack-Years 20 (16.4) 61 (50) 41 (33.6) 6 (46.2) 3 (23.1) 4 (30.8) 
 
Pilot Study: Subject Characteristics 
The Pilot Study population was composed of 50% females, with a mean age of 68 (+8.85) and 
white race predominance (79.7% white, 10.9% black, 0% hispanic, 9.4% other). The different 
histological types of tumors included Adenocarcinoma 42.2%, Squamous Cell Carcinoma 
32.8%, NSCLC 9.4%, Adenosquamous carcinoma 9.4%, SCLC 3.13%, Large Cell Carcinoma 
0%, Neuroendocrine 1.6%, and BAlCa 1.6%. All participants were ever smokers, 43.8% were 
current and 53.1% former. Sixty percent of the study population smoked for 30 to 60 years 
(median 40, interquartile range 17). The distribution according to cigarette dose exposure (pack-
years) was 15.6% (<30), 25% (30-44), 20.3% (45-59), 18.8% (60-74), 20.3% (>75) with a mean 
of 52 (+23.56) and a median of 50 pack-years (interquartile range 37).  
Slightly more than half of the patients (51.6%) had a positive family history of cancer. 
Among the participants, 15.6% had a first degree relative with a lung tumor and 4.7 % had a 
second degree relative with a lung tumor. Ten percent had a history of one family member with a 
Table 1 continued 
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tobacco related cancer; while for non-tobacco related cancer 21.9% had one family member and 
10.9% had two. 
A great majority of the patients reported a history of COPD/emphysema (57.1% with 
45.3% of missing data), or asthma (26.1%, 64.1% missing data) (bronchitis 0%).  
Since availability of PFT information in the Carinal Registry was our stratifying variable, 
50% of the patients in the Pilot Study had PFT information available by default. 
We can conclude that the Pilot Study is a good representation of its base sample, the 
Carinal Registry, given that the distribution of these variables does not significantly differ. 
3.1.2 Systematic Analysis of CT information. Characterize CT information 
The positive predictivity of the MARS ESP was 93.8%, given that in 60 of  64 cases we were 
able to find a CT study, leaving only 6.2% missing CT studies (4/64). Missing CT studies were 
seen among patients enrolled in earlier years. Between 2002 and 2005 there was 12% of missing 
CT studies, whereas the missing rate was null in the second half of the enrollment period (2006-
2009). The relationship between year of enrollment (2002-2005 vs. 2006-2009) and availability 
of CT was not statistically significant (p>0.05). Of the 60 CT studies found, 37 patients (62%) 
had a CT study before (and after) diagnosis, 19 patients (32%) had a CT only after diagnosis. On 
the 60 pa tients that CT studies were found, we were able to find a total of 381 t horacic CT 
studies (6.35 mean number of thoracic CT studies per subject, range 1-19 per subject).  
In some cases, the CT studies were suboptimal for emphysema scoring due to technical 
difficulties such as motion artifact, or disease-related problems such as pneumonia, pulmonary 
fibrosis, pleural effusion, and post-operative changes. However, only 2 patients had a single CT 
study available which had to be used for emphysema scoring regardless of image quality. 
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Forty nine patients (81.7%) had a pre-operative CT scan. These were defined by looking 
at the diagnosis and operative date, both available in Carinal Registry. A total of 120 pr e-
operative CT scans were found for these 49 patients, since in some instances there was more than 
one pre-operative CT scan. A total of 325 C T scans (85%) pertaining to 57 pa tients (95% of 
patients) were reconstructed using an edge-enhancing algorithm. Thirty-nine (65%) patients had 
both a pre-operative CT study with images reconstructed using the edge-enhancing algorithm (86 
CT scans) (Table 2). 
 
Table 2: Combination of CT scan acquisition sequence (before or after surgery) and edge-enhancing 
reconstruction protocol. 
Before 
+ Lung 
Before 
+ Other 
After 
+ Lung 
After 
+ Other Frequency 
Cumulative 
Frequency 
0 0 1 0 7 7 
0 0 1 1 4 11 
0 1 0 0 1 12 
0 1 0 1 2 14 
0 1 1 0 6 20 
0 1 1 1 1 21 
1 0 0 0 8 29 
1 0 1 0 15 44 
1 0 1 1 2 46 
1 1 1 0 10 56 
1 1 1 1 4 60 
 
Patients include the 60 patients from the Pilot Study with CT scans found. Legend: Before: CT scan obtained before 
surgery; After: CT scan obtained after surgery; Lung: edge-enhancing reconstruction available; Other: other 
reconstruction protocol available. Cumulative frequency adds up to 60, the number of patients for whom CT scans 
were found. 
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The slice thickness varied from 0.63mm to 8mm, but 5mm was the predominant CT scan 
slice thickness used among the Pilot Study series (79.4%). Eight CT studies (belonging to 7 
different patients) had more than one slice thickness. Of these 8 CT scans, 7 had two different 
slice thicknesses and one had three different slice thicknesses. 
The dose of the CT scan as measured in mA varied from 60mA (LDCT) to 751mA. 
Thirty-three percent (126/381) of the CT scans were done using CT image dose modulation, in 
which the dose is modulated throughout the thorax to obtain the best image quality at the lowest 
possible mA dose that varies depending on tissue density (18). These 126 CT scans pertained to 
42 patients (70%). 
We report a subjective finding from scoring patients with multiple CT studies, no 
information bias was encountered among those cases. The patients were scored equally 
effectively. The 381 cases scored for emphysema were not seen as independent studies but as 
series of studies related to one patient, since the CT studies could not be de-identified for this 
purpose. 
3.2 SPECIFIC AIM 2 
Specific Aim 2: To describe the distribution of emphysema scoring among lung cancer patients 
3.2.1 Visual CT Scan Emphysema Score Training Modules and Agreement with Experts 
The first training session showed excellent agreement with weighted kappa statistic k=0.82 (95% 
CI: 0.74-0.90). With the expert reading serving as gold standard, the trainee’s reading achieved a 
20 
sensitivity of 98% to detect any emphysema and 78% to detect more than trace. The second 
training session resulted in excellent agreement as well with a k=0.83 (95% CI: 0.73-0.91), and 
with a sensitivity of 96% to detect any emphysema and 74% to detect more than trace 
emphysema. There was only one instance in which there was disagreement by more than one 
category. The third and final training session showed fair to good agreement with a k=0.59 (95% 
CI 0.39-0.79). The sensitivity to detect any emphysema was 89% (95% CI: 67-99) and a 
sensitivity to detect more than trace emphysema of 94% (95% CI: 70-99). There was no 
disagreement by more than two categories. At this point the training was considered completed 
and the Pilot Study CT scans were read and scored for emphysema (Appendix B1, sections 1-3).  
3.2.2 Emphysema Scores Assessed by Visual Emphysema Scoring Method (VESM) 
Patients in the Pilot Study were scored for their emphysema following the NETT criteria. Their 
scores were compared to the expert’s score and weighted kappa showed poor agreement (k=0.27, 
95% CI: 0.14-0.40) and asymmetry (p=0.012) (Appendix B1, section 4). Due to these results, the 
expert score was used in further analysis. The distribution and severity of emphysema for both 
raters are shown in Figure 3A. Twenty-eight percent of the study population had no emphysema, 
21.1% trace, 31% mild, 15.8% moderate and 3.5% had severe emphysema. The frequency of 
missing data was only 10.9% (7/64). Demographics and smoking history organized by 
emphysema severity score are shown in Table 3. 
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Table 3: Pilot Study: Demographics and smoking by differential emphysema score (with percentages).  
 
Emphysema Score 
None Trace Mild Moderate Severe 
N (%) N (%) N (%) N (%) N (%) 
Sex 
9 (15.8) 5 (8.8) 8 (14.4) 7 (12.3) 1 (1.8) Female 
Male 7 (12.3) 7 (12.3) 10 (17.5) 2 (3.5) 1 (1.8) 
Age categories 
4 (7) 4 (7) 3 (5.3) 2 (3.5) 1 (1.8) 50-59 years 
60-69 years 4 (7) 4 (7) 4 (7) 3 (5.3) 1 (1.8) 
70-79 years 7 (12.3) 3 (5.3) 9 (15.8) 3 (5.3) 0 
>=80 years 1 (1.8) 1 (1.8) 2 (3.5) 1 (1.8) 0 
Race 
13 (22.8) 11 (19.3) 14 (24.6) 7 (12.3) 2 (3.5) White 
Black 2 (3.5) 0 2 (3.5) 1 (1.8) 0 
Other 1 (1.8) 1 (1.8) 2 (3.5) 1 (1.8) 0 
Smoker Status 
7 (12.3) 6 (10.5) 7 (12.3) 3 (5.3) 1 (1.8) Current Smoker 
Ex-smoker 9 (15.8) 6 (10.5) 9 (15.8) 6 (10.5) 1 (1.8) 
Pack Years categories 
4 (7) 1 (1.8) 4 (7) 0 0 <30 Pack-Years 
30-44 Pack-Years 5 (8.8) 2 (3.5) 4 (7) 0 1 (1.8) 
45-59 Pack-Years 2 (3.5) 3 (5.3) 4 (7) 2 (3.5) 0 
60-74 Pack-Years 2 (3.5) 2 (3.5) 4 (7) 4 (7) 0 
>75 Pack-Years 3 (5.3) 4 (7) 2 (3.5) 3 (5.3) 1 (1.8) 
 
Wilson et al. studied the distribution of emphysema among patients at high risk for lung 
cancer in the frame of the PLuSS study (10). They screened 3,642 community volunteers using 
low dose CT (LDCT) scans with a visual method for emphysema scoring similar to the one 
described in this manuscript. Their emphysema findings were 75.8% for any emphysema while 
ours were 71.9%. We found no difference in the emphysema distribution between the two patient 
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populations (p>0.05) (Table 4). Figure 3B shows the distribution of the different emphysema 
severity scores among both patient populations from the Pilot Study and Wilson et al. study (10) 
to have no statistically significant reason to state that the medians differ (p>0.05). 
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Figure 3.  Distribution of Emphysema Scores in the Pilot Study Population.  
CT scans were scored for emphysema based on the NETT criteria by the expert and trainee. A. Trainee vs. Expert 
CT scan Score Reading, Poor agreement as shown by low kappa score (see text); B. Carinal Registry Pilot Study 
emphysema score vs. Wilson et al. cases. Wilcoxon signed rank test: p=0.8574. Distributions do not differ 
significantly. 
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Table 4: Comparison of COPD variable and Visual Emphysema Score 
COPD variable from the medical record, Visual Emphysema Score from visually scoring CT scans for emphysema 
 
  
 Missing Not missing Emphysema 
 Study Group N Emphysema Measure N % N % N % 
1 Carinal cases  548 Medical Records [1] 228 41.6 320 58.4 214 66.9 
2 Carinal cases not in Random 
Subset 
484 Medical Records [1] 199 41.1 285 58.9 194 68.1 * 
3 Carinal Random Subset  64 Medical Records [1] 29 45.3 35 54.7 20 57.1 * 
4 Carinal Random Subset 64 Visual CT Score [2] 7 10.9 57 89.1 41 71.9** 
5 Carinal Random Subset 64 Visual CT Score >Trace [2] 7 10.9 57 89.1 29 50.9 
6 Wilson cases 99 Visual CT Score [3] 0 0 99 100 75 75.8** 
* p=0.1949 (chi-square) % of emphysema from medical record in Carinal Registry cases in 
random subset (Row 3) vs. Carinal Registry cases not in random subset (Row 2) 
** p=0.5980 (chi-square) %emphysema by CT in Wilson et al. cases (Row 6) vs. Carinal 
Registry sub-sample cases (Row 4)  
[1] Abstracted from medical records by laboratory investigators and recorded in Carinal Registry 
database 
[2] Expert reader 
[3] PLuSS procedure (8) 
 
3.3 SPECIFIC AIM 3 
3.3.1 Specific Aim 3a: To validate data in the Carinal Registry Database 
Validation of data in Carinal Registry & Pilot Study was carried out by analysis of the COPD 
variable and the VESM variable (Table 4). 
COPD was seen in a 66.9% of patients in the Carinal Registry, 68.1% of patients in the 
Carinal Registry (excluding the Pilot Study subset) and 57.1% of patients in the Pilot Study, with 
no significant difference in the distribution of disease (p>0.05), concluding that the Pilot Sample 
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is a good representation of the Carinal Registry. However, COPD data from the Carinal Registry 
and the Pilot Study yielded a frequency of missing data of 41.6% and 45.3% respectively.  On 
the other hand, the VESM among patients in the Pilot Study showed a f requency of any 
emphysema of 71.9% (or 50.9% for more than trace) with only 10.9% of missing data. 
Finally we also found that there was a 6 0% agreement between emphysema from the 
medical records (COPD/emphysema variable) and emphysema from CT scan reading (as per 
VESM variable) among the 64 pa tients in the Pilot Study subset (although the frequency of 
missing data from the COPD/emphysema variable was 39 = 60.1% of the data was missing). 
 
3.3.2 Specific Aim 3b: To assess the reproducibility of VESM. Intra-rater and Inter-rater 
variability 
Intra-rater variability of emphysema scores were assessed as a m easure of reliability. As 
mentioned above, CT scans from the training module were independently read twice by the same 
reader. Results were compared yielding a weighted kappa statistic of 0.83 (95% CI: 0.75-0.91). 
The test of symmetry was not statistically significant (p = 0.991). There was one instance where 
the emphysema score differed by more than one category (see also section 4.2.1). 
Inter-rater variability of emphysema scores was assessed as well. CT scans from the 
training module and from the Pilot Study were independently read twice and once respectively, 
by both the expert and trainee reader. The kappa scores of the training modules were presented 
above (sections 4.2.1 & 4.2.2, Figure 3A, and in more detail in Appendix B). 
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4.0  DISCUSSION 
Emphysema is a subtype of COPD and it has been shown to increase the risk of developing lung 
cancer independently from smoking (10-12). Many pathways are involved but a seemingly 
convincing theory lays in the inflammatory process shared both by smoking and emphysema due 
to the repeated injury and repair mechanisms with high cell turnover and subsequent increased 
possibility of genetic errors leading to the development of a neoplasia (7,8). 
We studied a large prospectively collected lung cancer case series and evaluated the data 
quality for the purposes of conducting research studies. A randomly selected Pilot Sample 
showed good correlation with its parental database, the Carinal Registry. The correlation of 
emphysema frequency (recorded from the medical history under the COPD/emphysema variable) 
among both the Carinal Registry and the Pilot Study patients was good showing no significant 
difference in COPD frequency distribution among both patients groups (Figure 4). These results 
strongly supported the design of the Pilot Sample as a sub-set of the Carinal Registry. 
We studied the distribution of emphysema among lung cancer patients in the Pilot 
Sample case series as evaluated by the Visual CT scan score method, and observed no 
differences when compared to the community based study by Wilson et al. (8) (71.9% vs. 75.8% 
respectively, p>0.05). This finding suggests that there might be a shared pathophysiolological 
pathway between emphysema and lung cancer independently of smoking. The frequency of 
emphysema by analysis of COPD/emphysema (from medical records) was lower than that 
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obtained with the Visual CT emphysema score method (VESM), we speculated one reason could 
be the impact of the high frequency of missing COPD data (41.6 and 45.3% ) (Table 4). 
Agreement between the frequency of COPD variable (yes/no) and VESM grouped (any/no) 
showed a high frequency of missing data (54.7%). However, we found a percent positive 
agreement of 60% and a percent agreement of 51.7% between these two measurements of 
COPD/emphysema in the same set of patients (Appendix C). 
There are a few disadvantages in the semi-quantitative VESM method. One is that it 
requires practice and training. The training required in this method can be regarded as being time 
consuming and, in this present study, final scoring still required the reading of an expert 
radiologist. As seen in Figure 3, the expert scores differ from the trainee scores (poor agreement 
as seen by a kappa score of 0.27) despite the excellent level of agreement reached in the training 
sessions (kappa=0.82, 0.83 and 0.59 for the first, second and final sessions respectively).  A 
possible explanation of the poor agreement is information bias since the reader was not blinded 
to the facts that the patients had a diagnosis of lung cancer and that they were smokers. In 
addition, the use of an edge enhancing reconstruction protocol to read most of the CT studies 
may have lowered the threshold to detect emphysema due to its better appreciation of lung 
parenchyma (20,21). Reproducibility of a method of research is critical in interpretation of 
results. This method showed high reproducibility and sensitivity to detect any emphysema (98, 
96, 89% for the 1st, 2nd and final training sessions respectively) but ultimately, the inter-rater 
agreement was poor (k=0.27). On the other hand, the frequency of missing data in the VESM 
method is lower and the accuracy of emphysema diagnosis is higher, so these findings support 
the extra effort in order to obtain high quality data for research purposes. 
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The strategy of using an automated medical records resource such as MARS EPS 
maximized the CT scans found, which is essential for the quality of the database and validity of 
analysis with low missing data, as shown in Table 4 where the missing results from CT and the 
missing COPD/emphysema data are shown. In order to expand this Visual CT Scan Scoring 
method (VESM) to the remaining 484 patients in the Carinal Registry, one single best CT scan 
from each patient would have to be selected for emphysema scoring. The MARS EPS would 
play an important role in generating this CT scan list. 
The best study would be defined as pre-operatively, preferably within one year of 
surgery/chemotherapy. The need for an edge-enhancing lung reconstruction remains 
controversial since in some studies it has shown to lower the threshold to detect mild emphysema 
(19,20). However, Vikgren et al. (21) found that edge-enhancing reconstruction is better than 
standard reconstruction to detect emphysema. As for the radiation dose, measured in mA, LDCT, 
in addition to lung cancer screening, has proven a good resource to evaluate the presence and 
severity of emphysema (22). Another strategy that has been successfully used to reduce the 
radiation dose to which the patients are exposed to is the dose modulation technique seen applied 
in several of the CT scans of this series (18). Slice thickness is another important factor in CT 
scanning. Cederlund et al. looked at CT scans during pre-operative evaluation for lung volume 
reduction surgery using an objective computer software method followed by subjective 
evaluation by 4 radiologists. They compared high resolution CT (HRCT, 2mm) with spiral CT 
(conventional 8-10mm) for classification of emphysema and found no difference between HRCT 
and spiral (60 & 62% agreement) (23). The study by Reske et al. agreed with their findings (20). 
On the other hand, another study by Cederlund et al. reported a slight benefit in using 
conventional spiral (47% vs. 40%) (p<0.05) (24). Both the slice thickness and the edge-
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enhancing reconstruction as parameters to select the best CT scan to diagnose and rate severity 
of emphysema remain inconclusive.  
Many factors may have contributed to limitations in this study. First, the CT training 
module is sub-optimally masked. It is blinded from the expert score, but it has personal 
identifiers (name, medical record number). The ideal training method would have been a de-
identified and randomly ordered list of the 96 CT scans. However, PACS is a cl inical 
entity/program that was not created for research purposes making it not a feasible option for the 
purposes of this manuscript. Furthermore, the fact that the PACS iSite system is site specific 
required the preparation of separate worklists; this fact not only makes training and reading more 
tedious but also can add lead population bias to the Visual CT Scan Scoring method, since the 
rater is not masked in terms of hospital site where the CT scan was acquired. In addition, the 381 
CT studies were not viewed as independent studies but as sub-series of studies associated to one 
particular patient and this could have biased the scoring related to preconcepts related to different 
hospitals. Second, the emphysema scoring method is semi-quantitative and subjective, since it 
does not use software designed to score emphysema based upon shades of black and white. Also, 
the CT studies reviewed were not obtained under a single protocol, many indeed differ on slice 
thickness and image resolution, and these factors may have contributed as well. As mentioned by 
Friedman and Reske et al. (19,20) the edge-enhancing lung reconstruction protocols may lower 
the threshold for emphysema detection and favor higher detection and severity scores, as found 
by the trainee reading of the CT scans in the Pilot Study. Third, the fact that it is known to the 
investigators that all the patients have lung cancer either from inclusion criteria or from simply 
seeing the visual manifestations of lung cancer on CT scan, may have biased the frequency and 
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the level of severity of emphysema scoring towards a greater severity of emphysema. All the 
factors mentioned above may contribute to information bias. 
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5.0  CONCLUSION 
This study shows that the Visual Emphysema Scoring Method is a very accurate method to score 
emphysema severity and carries a low frequency of missing data. When compared to the 
database information obtained from the medical record (COPD variable), the correlation between 
the two variables was poor. The VESM was a more accurate measure of COPD status among 
lung cancer patients enrolled in the Carinal Registry. 
Training in VESM showed high reproducibility scores and high sensitivity of the trainee 
to detect emphysema when compared to the standard expert score.  
In other words, the COPD variable is not a reliable indicator of emphysema among the 
Carinal Registry patients. In order to better assess their emphysema severity score, the VEMS 
would have to be used. After performing VESM among the 64 Pilot Study patients, there are 484 
remaining patients in the Carinal Registry. For practical reasons, we suggest that a single best CT 
scan has to be selected and we defined it as a preoperative study, within one year of surgery or 
diagnosis (if no s urgery performed), preferably with edge-enhancing reconstruction and thin 
slices (less than 5mm). 
 
31 
APPENDIX A 
ASSESSMENT OF AGREEMENT 
We evaluated inter-observer agreement of the Visual emphysema Scoring Method (VESM) 
between the trainee and the expert. Kappa agreement scores and specific tables are presented 
below. There were three training sessions, the first two involved reading and scoring 96 C T 
scans that were used for training purposes as well. The third and final training session involved 
reading and scoring 24 cases never seen by the trainee before. 
The first figure depicts the results of the trainee first time reading the training session of 
96 cases vs. the consensus expert reading and its kappa score and confidence interval showing 
excellent agreement. 
Landis & Koch, Values for kappa
Poor agreement beyond chance<.40
Fair to Good agreement beyond chance.40-.75
Excellent agreement>.75
Training Set of 96 cases
Trainee (1st session) Consensus (Standard)
 
Figure 4: Inter-reader agreement. 
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Results of the trainee’s first time reading of the training session were compared to the standard expert reading. 
Weighted kappa agreement was calculated and reference values used are shown in the right lower corner. 
 
 
The second figure shows the trainee second time reading the training session of 96 cases 
compared to the consensus expert reading and the agreement reached by the kappa score and 
confidence interval, evidence of excellent agreement. 
.
Training Set of 96 cases
Consensus (Standard)
Trainee (2nd session)
 
Figure 5: Inter-reader agreement. 
Results of the trainee’s second reading and comparison with the standard consensus expert score are shown. 
Agreement was calculated as weighted kappa score. 
 
The third and final training session is shown below. Although the kappa score showed 
poor agreement, the sample size was significantly smaller (24 instead of 96) partially explaining 
the lower agreement score. 
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Training Set of 24 cases
Trainee (3rd session) Consensus (Standard)
 
Figure 6: Inter-reader agreement. 
Agreement between the trainee and consensus standard panel in the last training session is shown here as weighted 
kappa score.  
 
This session shows the results of the Carinal Registry Pilot Sample scoring of the 64 
cases using the VESM both by the trainee and expert. The agreement reached was poor, as 
shown by a low kappa score. Several factors may have influenced this result. ....... 
Pilot Study sample size 57 
(7 vs. 4 missing)
Expert
Trainee
 
Figure 7: Results of the Pilot Sample CT scan reading.  
Agreement between the expert and trainee are shown as weighted kappa score. 
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We also evaluated intra-reader variability of the VESM by comparing the first and 
second trainee’s reading of the training session of the set of 96 series. The reproducibility was 
significantly high achieving a kappa score of 0.83. 
 
Training Set of 96 cases
Trainee (1st session) Trainee (2
nd session)
 
Figure 8: Intra-reader agreement.  
Agreement between the first and second session was calculated as weighted kappa.  
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APPENDIX B 
CORRELATION BETWEEN COPD VARIABLES 
We evaluated the correlation between the two variables indicating COPD in the Carinal Registry 
Pilot Study by cross-tabulating the COPD/emphysema variable (obtained from medical records) 
vs. VESM variable (visual emphysema score method, obtained by reading CT scans and scoring 
for emphysema). Visual emphysema severity scores other than none were grouped under a 
unique “Any” category. Data shown was obtained from Carinal Registry Pilot Sample, including 
both the trainee and the expert readings. Agreement was calculated by percent positive 
agreement and percent agreement. 
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B.1 EXPERT READING 
Table 5: Correlation between COPD and VESM variables (expert score).Table 5: Correlation between COPD and VESM variables (expert score) 
Frequency Missing = 35
29
100.00
7
24.14
22
75.86
Total
13
44.83
3
10.34
10
34.48
No
%
16
55.17
4
13.79
12
41.38
Yes
%
Total
%
No
%
Yes
%
Frequency
Percent
Any Emphysema by CTCOPD/Emphysema Medical Record
 
Percent Positive Agreement = 60%; Percent Agreement = 51.7% 
B.2 TRAINEE READING 
Table 6: Correlation between COPD and VESM variables (trainee score). 
Frequency Missing = 33
31
100.00
0
0.00
31
100.00
Total
13
41.94
0
0.00
13
41.94
No
%
18
58.06
0
0.00
18
58.06
Yes
%
Total
No
%
Yes
%
Frequency
Percent
Trainee Any Emphysema by CTCOPD/Emphysema Medical Record
 
Percent Positive Agreement = 73.5% 
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